Klow Stack — Klow + BPC-157 + TB-500 Bundle
The Klow stack is the most commonly logged Klow protocol: the standard Klow blend co-administered with additional standalone BPC-157 and TB-500 for the first phase of the cycle. The rationale is to front-load the two constituents with the steepest dose-response curves, then drop back to Klow monotherapy for the remainder.
When stacking makes sense
Tendon, ligament and post-surgical soft-tissue endpoints read out fastest under a stacked protocol. For dermal (GHK-Cu-led) and gut-mucosal (KPV-led) endpoints, Klow monotherapy is sufficient and stacking does not move the needle.
Stack composition
Klow blend at the loading dose for weeks 1–4, plus 250 mcg/day standalone BPC-157 and 250 mcg/day standalone TB-500. Drop to Klow-only at the maintenance dose for weeks 5–8.
Combined dose bounds
Combined daily BPC-157 across blend and overlay should stay under ~750 mcg. Combined daily TB-500 under ~1 mg. These bounds are conservative and based on published pre-clinical literature.
Operational notes
Stacked protocols mean three reconstituted vials open at once — label each with the date and your initials, and use a separate syringe per draw. Never mix peptides in the syringe barrel.
